US 2026/0234207 A1 · Keratin YK93-8, and Preparation Method Therefor, Pharmaceutical Composition Thereof and Use Thereof

Keratin YK93-8, and Preparation Method Therefor, Pharmaceutical Composition Thereof and Use Thereof

AssigneeInstitute of Materia Medica, Chinese Academy of Medical Sciences

InventorsShishan Yu, Xiaoguang Chen, Jing Jin, Yunbao Liu, Mi Li, Yong Li, Huimin Jiang, Xiaojing Wang, Guoru Shi, Mengyao Hao, Shuanggang Ma, Jing Qu, Shuying Li, Mingjin Wang, Guozhu Su, Jiang Fu

Life of this patent

Estimating the term…

Abstract

The present invention belongs to the field of biopharmaceuticals. Provided in the present invention are keratin YK93-8, a nucleic acid molecule encoding same, an expression vector containing the nucleic acid molecule, a host cell containing the expression vector or a host cell having the nucleic acid molecule integrated into the genome, as well as a method for preparing keratin YK93-8 and a pharmaceutical composition of keratin YK93-8. Further provided is the use of the above-mentioned keratin YK93-8 and other products in the preparation of drugs, such as a drug for treating hyperplasia of prostate, lymphoma, melanoma, breast cancer, lung cancer and uterine myoma, an analgesic, a lactation drug and a coagulant.

Claims17

Dependent claims

A keratin YK93-8, wherein the amino acid sequence of the keratin YK93-8 is:

(1) the amino acid sequence set forth in SEQ ID NO.1;
or
(2) an amino acid sequence formed by substitution, deletion or addition of 1-35 amino acids in the amino acid sequence set forth in SEQ ID NO.1 that maintains the same biological function.

Dependencies are inferred from the claim text.